Recto-vaginal Fistula Market Analysis and Demand With Forecast Overview to 2031

Recto-vaginal Fistula Market: Introduction

Recto-vaginal fistula can be described as abnormal epithelial line connected between the rectum and vagina. Fistulas can be the outcome of acquired etiologies or congenital malformations. Recto-vaginal fistulas can also be caused due to childbirth. Obstetric injury with a fourth or a third degree perineal tear or prolonged labor with necrosis of the part or episiotomy could result in recto-vaginal fistula.

Read Report Overview

Infection, breakdown of the repair, or improper repair can lead to development of fistula. Infections caused within the recto-vaginal septum can lead to the condition. Bartholin gland infections and crypto-glandular ano-rectal abscess drains cause low recto-vaginal fistula.

Hysterectomy is performed because of infection caused due to fistula. Lymph granuloma venereum and tuberculosis can result in recto-vaginal fistula. Primary classification of the condition is done with the help of etiology, size, and location. It categorizes the criteria for recto-vaginal fistulas as complex or simple. Classification of fistula is performed to plan proper treatment and appropriate therapy. Fistulas greater than 2.5 cm in diameter are termed as large and those less than 2.5 cm are considered small.

Request Brochure of Report –

Recto-vaginal Fistula Market: Key Trends

Rise in prevalence of Crohn’s disease resulting in occurrence of recto-vaginal fistula drives the global recto-vaginal fistula market. Crohn’s disease can be defined as an inflammatory bowel disease, wherein there is an inflammation of the digestive tract lining. Large number of women suffering from Crohn’s disease never develop recto-vaginal fistula. However, suffering from Crohn’s disease increases the risk of this condition. Hence, prevalence of recto-vaginal fistula is projected to rise during the forecast period owing to increase in incidence of Crohn’s disease.

Delivery-related injuries is a most common factor causing recto-vaginal fistulas. This includes perineum tear that extends to the bowel or an episiotomy infection, which is a surgical incision conducted to enlarge the perineum during the course of vaginal delivery. These could occur post a long, difficult, or otherwise obstructed labor. These kinds of fistula could also comprise injury to anal sphincter, the muscle rings at the end of the rectum that aids a person to hold. Hence, the incidence rate of recto-vaginal fistula is likely to increase due to rise in the rate of childbirth injuries during the forecast period.

Request for Custom Research

Presence of cancerous tumor in regions such as uterus, rectum, vagina, anal canal or cervix, can lead to development of recto-vaginal fistula. Moreover, radiation therapy undertaken to treat cancer in these body parts increases the risk of development of recto-vaginal fistulas. Past surgery in lower pelvic region, such as hysterectomy, can also result in development of recto-vaginal fistula. Therefore, rise in prevalence of pelvic cancer and surgery in lower pelvic region are projected to drive the global recto-vaginal fistula market.

The world is presently struggling with COVID-19 pandemic. COVID-19 leads to pneumonia, severe and acute respiratory disorders, multiple organ failure, and, in severe cases, death. The geriatric population is more prone to COVID-19. The pandemic has hampered the growth of the global recto-vaginal fistula market.

Governments of developing countries are making significant investments to modernize health care infrastructure in their respective countries, which is likely to increase access to health care. This is projected to increase the demand for recto-vaginal fistula treatment.

North America to Capture Major Share of Global Recto-vaginal Fistula Market

North America is anticipated to dominate the global recto-vaginal fistula market from 2024 to 2031. This is attributed to favorable regulatory environment, rise in focus and interest in recto-vaginal fistula research & development, and government funding for life sciences research. Additionally, well-established and high quality infrastructure drives the market in North America. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to rise in research and developmental activities, increase in government initiatives for improving health care, and surge in focus of key players in building or strengthening presence in the region.

Pre Book Rectovaginal Fistula Market Report –

Key Players Operating in Global Recto-vaginal Fistula Market

The global recto-vaginal fistula market is highly consolidated due to the presence of small number of key players. These players hold major market share in their respective regions. Growth strategies adopted by leading players are likely to drive the global recto-vaginal fistula market.

Major players operating in the global recto-vaginal fistula market are listed below:

  • Takeda Pharmaceutical Company Limited
  • Cook
  • Pfizer, Inc.
  • Other Prominent Players

More Trending Reports by Transparency Market Research –

Abdominal Surgical Robot Market:

Smart Healthcare Products Market:

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453